Stocks and Investing
Stocks and Investing
Fri, January 7, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Lewis Maintained (AXNX) at Buy with Decreased Target to $73 on, Jan 7th, 2022
David Lewis of Morgan Stanley, Maintained "Axonics, Inc." (AXNX) at Buy with Decreased Target from $74 to $73 on, Jan 7th, 2022.
David has made no other calls on AXNX in the last 4 months.
There are 2 other peers that have a rating on AXNX. Out of the 2 peers that are also analyzing AXNX, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Mike Matson of "Needham" Maintained at Strong Buy with Decreased Target to $62 on, Tuesday, December 14th, 2021
- Danielle Antalffy of "SVB Leerink" Maintained at Buy with Increased Target to $85 on, Friday, November 5th, 2021
Contributing Sources